Drug Trial Radar · NCT07629583
To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
Last checked: Nov 20, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
46
Planned (sponsor's estimate)
Start
Nov 2, 2026
Primary completion
Mar 29, 2030
Study completion Mar 29, 2030
Sponsor
- Lead sponsor
- Genentech, Inc.Roche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Jun 5, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cevostamab in participants with systemic lupus erythematosus (SLE) with or without active lupus nephritis (LN).
Conditions
- Lupus Erythematosus, Systemic
Interventions
CevostamabDrug
Participants will receive cevostamab IV as per the schedule given in the protocol.
TocilizumabDrug
Tocilizumab may be used as rescue medication for participants who experience a cytokine release syndrome (CRS) event.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants with Adverse Events (AEs)Time frame: Up to approximately 52 weeks
Locations
11 sites in 6 countries. Site status is shown where the registry gives one.
Royal Melbourne Hospital
Parkville, Victoria, Australia · Recruiting
Hospital Moinhos de Vento
Porto Alegre, Rio Grande do Sul, Brazil · Recruiting
Hospital de Clnicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil · Recruiting
Hospital das Clínicas FMRP-USP
Ribeirão Preto, São Paulo, Brazil · Recruiting
Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto
Sao Jose Rio Preto, São Paulo, Brazil · Recruiting
Peking University First Hospital
Beijing, Beijing Municipality, China · Recruiting
Peking University People's Hospital
Beijing, Beijing Municipality, China · Recruiting
Pingxiang People's Hospital
Pingxiang, Jiangxi, China · Recruiting
Hopital Rangueil
Toulouse, Haute Garonne, France · Recruiting
Istituto Clinico Humanitas
Rozzano, Lombardy, Italy · Recruiting
Hospital Universitario Virgen Macarena
Seville, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.